Advancement in Endodontic Microsurgical Instruments is expected to drive the market growth.
Endodontic surgery was viewed as a last resort due to inappropriate equipment, surgical areas with poor visibility, and an elevated risk of postoperative complications. However, with advancements in illumination, magnification, equipment, and materials, endodontic surgery has evolved into endodontic microsurgery. Higher magnification and tiny tools have improved the clinical outcome of endodontic surgery. Traditional endodontic surgical instruments are too bulky for the small osteotomy sites of microsurgery. Few of the devices used in microsurgery are miniature versions of traditional instruments. Endodontic microsurgery, which employs micro-instruments, is a less invasive treatment approach with predictable outcomes. Microsurgery has a high success record of about 93.5 percent, giving it a dependable alternative for managing periapical pathology when surgical root treatment is not possible. Clinicians have achieved improved success rates thanks to innovative approaches designed to overcome the limitations observed in traditional endodontic surgery. Along with micro-instruments, biomimetic materials have resulted in favorable endodontic surgery outcomes. Thus, from the above statements, the market is expected to drive in the forecast period.
Download Free Sample: https://www.datamintelligence.com/download-sample/microsurgery-market
High costs of the surgeries, lack of reimbursement policies, lack of skilled healthcare professionals and side effects associated with the surgeries are some of the factors the market is expected to get hampered in the forecast period.
The microsurgery market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, reimbursement scenario, pricing analysis etc.
COVID-19 Impact Analysis:
The COVID-19 pandemic has moderately impacted healthcare systems and the market. Several surgeons worldwide in the field of cosmetic surgery have self-imposed a suspension of all aesthetic surgery treatments advised by most international scientific associations, which has had a significant economic impact on most private clinics.
Canceling elective surgeries had a tremendous impact on people and had long-term, potentially disastrous effects on healthcare systems worldwide, slowing market revenue growth. However, the pandemic’s increasing cases of chronic diseases raised the demand for microsurgery treatments. Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.
Free Flap Tissue Transfer segment is expected to hold the largest market share in microsurgery market
The free flap tissue transfer segment is expected to dominate in 2021. The segment benefits because free flap surgery, also known as free tissue transfer, is a reconstructive surgical method involving transferring skin or tissue from one section of the body to another. At the same time, a major vein or artery remains linked to the tissue being transplanted. The perfusion and drainage of the flap and its survival are ensured in the latter stages of this procedure. The ability to transfer living tissue from one body part to another has greatly simplified complex defect reconstruction. This method has several advantages, including stable wound covering, improved functional and aesthetic outcomes, less donor site morbidity, and the ability to use vascularized tissue from remote body parts outside the region of damage. Microsurgical free flap reconstruction employs a variety of surgical flaps to meet the needs of the recipient site. The options include cutaneous, bone, muscular, or a combination. Therefore, it has increased the demand for the procedure. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
Visit The Full Report: https://www.datamintelligence.com/research-report/microsurgery-market
North America region holds the largest market share in the global microsurgery market
In 2021, North America accounted for the highest revenue share. The increasing prevalence of cancer and neurological disorders, adoption of highly advanced microsurgical equipment, well-established infrastructure, and product launches by the key market players are some factors the market is expected to boost in the forecast period. For instance, In the United States in 2019, 1,752,735 new cancer cases were reported and 599,589 cancer deaths. 439 new cancer cases were reported for every 100,000 people, and 146 individuals died from cancer. In Contrast, 1.9 million new cancer cases will be diagnosed in the United States in 2021, with 608,570 cancer fatalities. Therefore, it has increased the demand for microsurgery.
Moreover, on May 26, 2022, micro medical instruments, a robotics firm dedicated to producing clinical experiences for microsurgery patients, unveiled a new simulator dubbed symani surgical system simulator for microsurgery. The advanced system is designed to help doctors perform better procedures. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.
Major key players in the microsurgery market are ZEISS International, and Hu-Friedy Mfg. Co., LLC, MicroSurgical Technology, Aesculap, Inc., Peter Lazic Gmbh, Synovis Life Technologies, Inc., Aros Surgical, Medline Industries, LP, Aurolab, Beaver-Visitec International.
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States